Treatment of Periodontitis by Tulsi Gel

Launched by AL-AZHAR UNIVERSITY · Nov 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a new treatment for Stage II periodontitis, which is a serious gum disease. Specifically, researchers want to compare two types of gels: a 4% Tulsi gel, made from the holy basil plant, and a 1% Chlorohexidine gel, which is a common antiseptic. The goal is to see which gel works better in helping patients with this gum disease. Participants will have their gum health measured at the start of the study, then again after one month and three months to track improvements.

To be eligible for this trial, participants should be between 30 and 50 years old and must have Stage II periodontitis. It’s important that they do not have any other health issues or medications that could interfere with the study's results. Pregnant or breastfeeding women, as well as those who have had certain dental treatments recently, will not be able to join. This study is not yet recruiting participants, but once it starts, those who qualify will be able to contribute to important research that could improve gum disease treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients included in this study will be having advancedI Periodontitis
• • Aging from 30 to 50 years old
• • Free from any local or systemic risk factors that may affect the results of the study.
• Exclusion Criteria:
• • Long-term therapy with medications within a month prior to enrollment that could affect periodontal status or healing.
• • Pregnant woman and lactating mothers.
• • Patients with previous periodontal treatment including scaling and root planning and periodontal surgery in the last 3 and 6 months, respectively.